A LinkedIn post from Gallant highlights an upcoming Gallant U webinar aimed at the veterinary community on stem cell therapy. The session is scheduled for March 18 at 7:00 p.m. ET and will feature Rebecca Windsor, DVM, DACVIM, the company’s Director of Veterinary Affairs, with a live Q&A component.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post indicates that the event is RACE-approved and offers one continuing education credit, positioning it as a formal professional development opportunity. For investors, this suggests an emphasis on clinician education and thought-leadership in veterinary regenerative medicine, which may support longer-term adoption of Gallant’s offerings and deepen relationships with veterinary practices.
By addressing frequently asked questions about stem cell therapy, the initiative could help reduce knowledge barriers around advanced treatments and potentially increase clinical comfort with these services. If successful, such educational outreach may indirectly contribute to higher utilization of Gallant’s platform over time, reinforcing its competitive position in a specialized and evolving segment of the animal health market.